Fig. 3

Biocompatibility and anti-inflammatory activity of CB/Lid-n. a Fluorescent images of live/dead staining assay, scale bar: 400 µm; b percentage of live cells and dead cells in each group; c a device diagram of modified CCK-8 assay; d relative cell viability of L929 cells co-cultivated with CB/Lid-n; e hemolysis ratio of red blood cells co-incubated with CB/Lid-n; f immunofluorescence images of IL-6 and IL-10, scale bar: 100 µm; g quantiative results of immunofluorescence images; h relative mRNA expression of IL-6 and IL-10. Values are expressed as the mean ± SD (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001